April 7, 2016
Terry Mahn Quoted in Law360's "High Court Biosimilar Drama Intact After Amgen-Apotex Denial"
Article posted on Law360, December 12, 2016
The U.S. Supreme Court’s refusal Monday to review a major biosimilar ruling involving Amgen and Apotex doesn’t necessarily mean that justices agree with the ruling, according to attorneys who predict that justices may use a separate case to tackle the same question about notice of biosimilar sales.
“Having dismissed the Amgen v. Apotex petition leaves the law as it is but doesn’t necessarily mean the court isn’t going to decide it,” Fish & Richardson P.C. principal Terry G. Mahn said. “This could be a total nonevent.”
To read the full article, click here.
May 14, 2021
Massachusetts Lawyers Weekly Named Fish & Richardson Principal Andrew Pearson an "Up & Coming Lawyer"
March 13, 2023
Fish & Richardson Names Joshua A. Griswold as Managing Principal of Dallas Office
December 5, 2016
Juanita Brooks and Jon Singer profiled in National Law Journal's special report "High Stakes, Significant Victories"
July 17, 2017
Fish & Richardson Elects Deanna Reichel as a Principal
February 17, 2009
Fish Receives Top Rankings in IP Law360 Surveys
July 14, 2014
Fish & Richardson Sends 33 Students to Space Camp
October 12, 2018
Fish & Richardson Associate Jared Smith Receives Pro Bono Publico Award
February 12, 2009
Corporate and Chancery Year in Review: Top 10 Delaware Corporate Opinions of 2006
May 5, 2013